Business
HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference
HLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference ...
About this update from Hls Therapeutics, Inc.
[{"type":"text","content":"\n\n\n\nHLS Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, Feb. 19, 2019\n\n\n\nTORONTO, Feb. 19, 2019 /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX: HLS), a specialty pharmaceutical company focused on central nervous system and cardiovascular markets, announces that Greg Gubitz, the Company's Chief Executive Officer, is scheduled to present a general company update at the 8th Annual SVB Leerink Global Healthcare Conference on Friday, March 1, 2019, at 10:00 a.m. Eastern Time in New York City.\nA live audio webcast of the presentation will be available at: http://wsw.com/webcast/leerink32/hls.v/, and will be accessible at the same link for 30 days.\nABOUT HLS THERAPEUTICS INC. \nFormed in 2015, HLS is a specialty pharmaceutical company focused on the acquisition and commercialization of late stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. HLS's focus is on products targeting the central nervous system and cardiovascular therapeutic areas. HLS's management team is composed of seasoned pharmaceutical executives with a strong track record of success in these therapeutic areas and at managing products in each of these lifecycle stages.\nFORWARD LOOKING INFORMATION\nThis release includes forward-looking statements regarding HLS and its business. Such statements are based on the current expectations and views of future events of HLS's management. In some cases the forward-looking statements can be identified by words or phrases such as \"may\", \"will\", \"expect\", \"plan\", \"anticipate\", \"intend\", \"potential\", \"estimate\", \"believe\" or the negative of these terms, or other similar expressions intended to identify forward-looking statements, including, among others, statements with respect to HLS's pursuit of additional product and pipeline opportunities in certain therapeutic markets, statements regarding growth opportunities and expectations regarding financ...